Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6280105

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.c1ccc2oc(SCCCN3CCNCC3)nc2c1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 3/20 0.53
ALDH1A1 P00352 4/20 0.51
HPGD P15428 3/20 0.51
TSHR P16473 2/20 0.51
GAA P10253 1/20 0.51
MAPK1 P28482 1/20 0.51
HSD17B10 Q99714 1/20 0.51
MEN1 O00255 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
HTR1A P08908 1/20 0.47
DRD2 P14416 1/20 0.47
HTR2A P28223 1/20 0.47
HTR7 P34969 1/20 0.47
HTR6 P50406 1/20 0.47
TMEM97 Q5BJF2 1/20 0.46
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1705470 0.94 SOAT1 (0.52) SOAT1ALDH1A1HPGDTSHRGAA
Trifluoroacetic Acid SCHEMBL6282990 0.85 SOAT1 (0.48) SOAT1ALDH1A1DRD2LMNAPOLB
SCHEMBL13755906 0.83 DDAH1 (0.56) SOAT1ALDH1A1HPGDTSHRGAA
Hydrochloric Acid SCHEMBL1705421 0.81 DDAH1 (0.55) SOAT1ALDH1A1HPGDTSHRGAA
Trifluoroacetic Acid SCHEMBL6282019 0.81 SOAT1 (0.41) SOAT1ALDH1A1HPGDGAAMEN1
Trifluoroacetic Acid SCHEMBL1704553 0.80 TMEM97 (0.48) SOAT1ALDH1A1HPGDMEN1HTT
Trifluoroacetic Acid SCHEMBL6279616 0.79 SOAT1 (0.54) SOAT1ALDH1A1LMNAPOLB
Trifluoroacetic Acid SCHEMBL5623338 0.78 ALDH1A1 (0.40) SOAT1ALDH1A1MEN1HTTKMT2A
Trifluoroacetic Acid SCHEMBL30040872 0.78 SOS1 (0.54) MEN1KMT2ADRD2
Trifluoroacetic Acid SCHEMBL6282854 0.75 KDM4E (0.41) SOAT1ALDH1A1TSHRMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6969711-B2 Cyclic diamine compounds and medicine containing the same KOWA COMPANY, LTD. (JP) 2005-11-29 US disclosed
EP-0987254-B1 NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME KOWA CO (JP) 2004-12-22 EP disclosed
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same KOWA COMPANY, LTD. (JP) 2004-02-26 US disclosed
EP-0987254-A1 NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME Kowa Co., Ltd. (JP) 2000-03-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same LCAT, ACAT2, ACAT1 SOAT1 5/4885ALDH1A1 307/4885HPGD 939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.